A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit the Mcl-1 protein—an essential survival factor for therapy-resistant ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus ...

Exelixis, Inc. and Natera , a global leader in cell-free DNA and precision medicine, today announced their collaboration on the planned Exelixis-sponsored STELLAR-316 trial. This randomized phase 3 ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Severe valvular heart disease was not uncommon among patients with cancer, and intervention to manage the valvular disease ...

Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...

The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

“Our goal is clear: to transform the cancer experience from fragmented and burdensome to equitable, connected, and ...